BG65204B1 - Фармацевтичен състав, фармацевтичен кит и използването им като противозачатъчно средство - Google Patents

Фармацевтичен състав, фармацевтичен кит и използването им като противозачатъчно средство Download PDF

Info

Publication number
BG65204B1
BG65204B1 BG106533A BG10653302A BG65204B1 BG 65204 B1 BG65204 B1 BG 65204B1 BG 106533 A BG106533 A BG 106533A BG 10653302 A BG10653302 A BG 10653302A BG 65204 B1 BG65204 B1 BG 65204B1
Authority
BG
Bulgaria
Prior art keywords
drospirenone
ethinylestradiol
composition
amount
active agent
Prior art date
Application number
BG106533A
Other languages
Bulgarian (bg)
English (en)
Other versions
BG106533A (bg
Inventor
Wolfgang Heil
Juergen Hilman
Ralph Lipp
Renate Heithecker
Original Assignee
Schering Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26153358&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BG65204(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Aktiengesellschaft filed Critical Schering Aktiengesellschaft
Publication of BG106533A publication Critical patent/BG106533A/bg
Publication of BG65204B1 publication Critical patent/BG65204B1/bg

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
BG106533A 1999-08-31 2002-03-20 Фармацевтичен състав, фармацевтичен кит и използването им като противозачатъчно средство BG65204B1 (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24095399P 1999-08-31 1999-08-31
EP99202826 1999-08-31

Publications (2)

Publication Number Publication Date
BG106533A BG106533A (bg) 2002-10-31
BG65204B1 true BG65204B1 (bg) 2007-07-31

Family

ID=26153358

Family Applications (2)

Application Number Title Priority Date Filing Date
BG106533A BG65204B1 (bg) 1999-08-31 2002-03-20 Фармацевтичен състав, фармацевтичен кит и използването им като противозачатъчно средство
BG109749A BG109749A (bg) 1999-08-31 2002-03-20 Фармацевтичен състав, фармацевтичен кит, използването им за инхибиране на овулация и метод за получаване

Family Applications After (1)

Application Number Title Priority Date Filing Date
BG109749A BG109749A (bg) 1999-08-31 2002-03-20 Фармацевтичен състав, фармацевтичен кит, използването им за инхибиране на овулация и метод за получаване

Country Status (11)

Country Link
CN (1) CN1223350C (no)
BG (2) BG65204B1 (no)
CA (1) CA2382426C (no)
EE (1) EE05317B1 (no)
HR (1) HRP20020258B1 (no)
IL (2) IL197396A (no)
MX (1) MXPA02002043A (no)
NO (3) NO327588B3 (no)
RU (4) RU2269342C2 (no)
SK (1) SK287634B6 (no)
UA (1) UA81387C2 (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1625849A1 (en) * 2004-08-09 2006-02-15 Liconsa, Liberacion Controlada de Sustancias Activas, S.A. Pharmaceutical composition comprising drospirenone and ethynylestradiol
CN101489563A (zh) * 2006-07-06 2009-07-22 拜耳先灵医药股份有限公司 用于避孕和预防先天性畸形风险的药物制剂
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
BR112014012444B1 (pt) 2011-11-23 2021-12-14 Therapeuticsmd, Inc Composição farmacêutica compreendendo estradiol solubilizado, progesterona e um agente de solubilização, bem como usos desta para tratar um sintoma relacionado à menopausa em uma mulher
RU2618471C2 (ru) * 2012-12-03 2017-05-03 Закрытое Акционерное Общество "Вертекс" Пероральная фармацевтическая композиция диуретика и ингибитора АПФ в микронизированной форме, лекарственное средство и его применение
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
JP2017516768A (ja) 2014-05-22 2017-06-22 セラピューティックスエムディー インコーポレーテッドＴｈｅｒａｐｅｕｔｉｃｓｍｄ， Ｉｎｃ． 天然の併用ホルモン補充療法剤及び療法
CN108606963B (zh) * 2017-12-27 2021-05-18 上海长海医院 含有屈螺酮和雌激素的复方避孕贴、制备方法及应用
CN111529482A (zh) * 2020-05-20 2020-08-14 祝培 十一酸睾酮缓释植入剂及其应用

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2652761A1 (de) * 1976-11-16 1978-05-18 Schering Ag Neue spirolactone und verfahren zu deren herstellung

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4344462C2 (de) * 1993-12-22 1996-02-01 Schering Ag Zusammensetzung für die Empfängnisverhütung
DE4411585A1 (de) * 1994-03-30 1995-10-05 Schering Ag Pharmazeutisches Kombinationspräparat zur hormonalen Kontrazeption
ES2223081T3 (es) * 1996-07-26 2005-02-16 Wyeth Metodo anticonceptivo oral monofasico y kit que comprende una combinacion de progestina y estrogeno.

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2652761A1 (de) * 1976-11-16 1978-05-18 Schering Ag Neue spirolactone und verfahren zu deren herstellung

Also Published As

Publication number Publication date
RU2010114825A (ru) 2011-10-20
HRP20020258B1 (en) 2007-05-31
RU2449796C2 (ru) 2006-02-10
MXPA02002043A (es) 2003-08-20
IL200482A0 (en) 2011-07-31
CN1223350C (zh) 2005-10-19
SK287634B6 (sk) 2011-04-05
UA81387C2 (en) 2008-01-10
IL197396A (en) 2010-04-29
EE200900049A (et) 2009-10-15
CN1407895A (zh) 2003-04-02
RU2396082C2 (ru) 2010-08-10
RU2449796C9 (ru) 2007-10-27
NO2010004I1 (no) 2010-03-22
RU2005131868A (ru) 2007-04-20
NO327588B3 (no) 2011-05-16
RU2269342C9 (ru) 2007-10-27
NO327588B1 (no) 2009-08-31
EE05317B1 (et) 2010-08-16
RU2269342C2 (ru) 2006-02-10
BG109749A (bg) 2008-06-30
CA2382426C (en) 2006-02-28
BG106533A (bg) 2002-10-31
HRP20020258A2 (en) 2005-02-28
NO20083854L (no) 2002-04-26
RU2482853C2 (ru) 2013-05-27
SK2572002A3 (en) 2002-11-06
CA2382426A1 (en) 2001-03-08
NO20091809L (no) 2002-04-26

Similar Documents

Publication Publication Date Title
US6787531B1 (en) Pharmaceutical composition for use as a contraceptive
AU2005202046B9 (en) Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive
EP1611892B1 (en) Pharmaceutical compositions comprising drospirenone
RU2482853C2 (ru) Фармацевтическая композиция, способ ее получения и многофазный фармацевтический препарат для ингибирования овуляции у млекопитающего
AU2014227490A1 (en) Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive
EP2305267A2 (en) Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive
ZA200404083B (en) Pharmaceutical combination of ethinylestradiol anddrospirenone for use as a contraceptive.